Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
180,181,824
-
Total 13F shares
-
94,552,324
-
Share change
-
+8,466,746
-
Total reported value
-
$187,180,490
-
Price per share
-
$1.98
-
Number of holders
-
77
-
Value change
-
+$18,089,983
-
Number of buys
-
26
-
Number of sells
-
42
Institutional Holders of Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) as of Q1 2024
As of 31 Mar 2024,
Compass Therapeutics, Inc. - Common Stock, $0.0001 par value per share (CMPX) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
94,552,324 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., JANUS HENDERSON GROUP PLC, Blackstone Inc., BlackRock Inc., Cormorant Asset Management, LP, Rock Springs Capital Management LP, FMR LLC, VANGUARD GROUP INC, and Vivo Capital, LLC.
This page lists
77
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.